Evaluation of efficacy of pharmacotherapy treatment of COVID- 19 infection using oral Levamisole and Formoterol+Budesonide inhaler and comparison of this treatment protocol with standard national treatment of the disease

Fasa University of Medical Sciences0 sites30 target enrollmentTBD

Overview

Phase: Phase 2
Intervention: Not specified
Conditions: Not specified
Sponsor: Fasa University of Medical Sciences
Enrollment: 30
Status: Completed
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Fasa University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

•COVID\-19 positive patients with positive, PCR and chest CT scan

Exclusion Criteria

•Patients with sever respiratory problems including patients with:1\. Spo2\<60%2\. Severe respiratory distress3\. Heamodynamic instabilitty 4\. Acid base disturbance 5\. Severe Anemia
•Patients with hepatic diseases
•Patients with Nervous system diseases

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed

N/A

Evaluation of Therapeutic Efficacy of Lekhaniya Mahakashaya in Obesity

CTRI/2022/03/041240alit Hari PG State Ayurvedic College And Hospital Pilibhit40

Completed

N/A

Clinical analysis for the efficacy of the treatment with hemoptysis and chronic hemosputum -A retrospective, single center, observational studyhemoptysis

JPRN-UMIN000042050Department of Respiratory Medicine in National Center for Global health and Medicine180

Active, Not Recruiting

Phase 2

iquid biopsy for treatment guidance in cancerHealth Condition 1: C00-D49- Neoplasms

CTRI/2019/02/017548Datar Cancer Genetics Limited

Completed

N/A

Clinical study to evaluate the efficacy, pharmacokinetics and safety of immunoglobulin intravenous (human) 10% (NewGam) in patients with primary immunodeficiency diseasesPrimary immunodeficiency diseases (PID)Haematological DisordersCommon variable immunodeficiency

ISRCTN05425999Octapharma AG (Switzerland)50

Recruiting

Phase 3

Comparison of the effectiveness of pharmacotherapy with sertraline versus Glaser reality therapy in social anxiety disorderSocial anxiety.Anxiety disorder due to known physiological conditionF06.4

IRCT20191106045356N4Yazd University of Medical Sciences75